# Jennifer Gudeman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jennifer-gudeman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 117 |
| Field | Sleep and Wakefulness Research |
| h-index | 6 |
| i10-index | 5 |
| Last Known Institution | Momenta Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5080421641 |
| ORCID iD | 0000-0002-7375-5020 |
| Works | 88 |

## Researcher papers

- [Demographic characteristics and comorbidities of patients with narcolepsy: a propensity-matched cohort study](https://scholariq.org/papers/demographic-characteristics-and-comorbidities-of-patients-with-narcolepsy-a/)
- [Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System](https://scholariq.org/papers/evidence-of-accidental-dosing-errors-with-immediate-release-sodium-oxybate-data/)
- [Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial](https://scholariq.org/papers/efficacy-of-once-nightly-sodium-oxybate-ft218-in-narcolepsy-type-1-and-type-2/)
- [Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers](https://scholariq.org/papers/randomized-crossover-open-label-study-of-the-relative-bioavailability-and-safety/)
- [A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient’s Perspective](https://scholariq.org/papers/a-survey-of-people-living-with-narcolepsy-in-the-usa-path-to-diagnosis-quality/)
- [Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment](https://scholariq.org/papers/clinician-preferences-for-oxybate-treatment-for-narcolepsy-survey-and-discrete/)
- [0579 Long-Term Safety of Once-Nightly Oxybate for Narcolepsy: RESTORE Study Interim Analysis of Data](https://scholariq.org/papers/0579-long-term-safety-of-once-nightly-oxybate-for-narcolepsy-restore-study/)
- [Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial](https://scholariq.org/papers/improvement-in-sleep-latency-with-extended-release-once-nightly-sodium-oxybate/)
- [Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) Trial](https://scholariq.org/papers/weight-loss-with-once-nightly-sodium-oxybate-for-the-treatment-of-narcolepsy/)
- [Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial](https://scholariq.org/papers/efficacy-of-once-nightly-sodium-oxybate-ft218-on-daytime-symptoms-in-individuals/)
- [0732 Drug Class Utilization and Age-Related Trends in Narcolepsy and Idiopathic Hypersomnia: A Claims Database Analysis](https://scholariq.org/papers/0732-drug-class-utilization-and-age-related-trends-in-narcolepsy-and-idiopathic/)
- [RELATIVE PREVALENCE OF IDIOPATHIC HYPERSOMNIA, NARCOLEPSY TYPE 1, AND NARCOLEPSY TYPE 2: A CLAIMS DATABASE ANALYSIS](https://scholariq.org/papers/relative-prevalence-of-idiopathic-hypersomnia-narcolepsy-type-1-and-narcolepsy/)

## Researcher topics

- [Sleep and Wakefulness Research](https://scholariq.org/topics/sleep-and-wakefulness-research/)
- [Sleep and related disorders](https://scholariq.org/topics/sleep-and-related-disorders/)
- [Sleep and Work-Related Fatigue](https://scholariq.org/topics/sleep-and-work-related-fatigue/)
- [Restless Legs Syndrome Research](https://scholariq.org/topics/restless-legs-syndrome-research/)
- [Mind wandering and attention](https://scholariq.org/topics/mind-wandering-and-attention/)

## Researcher university

- [Momenta Pharmaceuticals (United States)](https://scholariq.org/institutions/momenta-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.